23BPG - Overview: 2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine

Test Catalog

Test Name

Test ID: 23BPG    
2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine

Useful For Suggests clinical disorders or settings where the test may be helpful

Screening for mast cell activation disorders including systemic mastocytosis


2,3-Dinor-11beta-prostaglandin F2 alpha (2,3 BPG) is elevated in the urine of patients with systemic mastocytosis (SM).


2,3 BPG should be used as a screening test for systemic mastocytosis.


When 2,3 BPG is used in combination with urinary leukotriene E4 (LTE4) and N-methyl histamine (NMH), the sensitivity for SM detection increases to 90%.

Additional Tests Lists tests that are always performed, at an additional charge, with the initial tests

Test IDReporting NameAvailable SeparatelyAlways Performed
AACTCreatinine, UNoYes

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

When this test is performed, urine creatinine will always be performed at no additional charge.

Special Instructions and Forms Library of PDFs including pertinent information and consent forms, specimen collection and preparation information, test algorithms, and other information pertinent to test

Method Name A short description of the method used to perform the test

23BPG: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

AACT: Enzymatic Colorimetric Assay

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Reporting Name A shorter or abbreviated version of the Published Name for a test; an abbreviated test name

2,3-dinor 11B-Prostaglandin F2a, U

Aliases Lists additional common names for a test, as an aid in searching

2,3 11 Beta-Prostaglandin F2 Alpha
11 Beta-Prostaglandin F2 Alpha